|
Composition |
|
Prednisolone Acetate USP |
1% w/v |
Benzalkonium Chloride NF |
0.006 % w/v |
(as preservative) |
|
Aqueous Vehicle |
q.s. |
|
|
Dosage Form |
Ophthalmic Suspension (Eye Drops) |
|
Category |
Corticosteroid |
|
Description |
Prednisolone acetate is a topical anti-inflammatory agent inhibits the edema, fibrin deposition, capillary dilation and phagocytic migration of the acute inflammatory response, as well as capillary proliferation, deposition of collagen and scar formation. |
|
Indications |
Prednisolone acetate is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. |
|
Dosage |
Instill one to two drops into the sac two to four times daily. Care should be taken not to discontinue therapy prematurely. |
|
Contraindications |
Most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, Mycobacterial infection of the eye and fungal diseases of ocular structures Or Individuals with known or suspected hypersensitivity to any of the ingredients of this preparation. |
|
Warnings & Precautions |
Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity, and fields of vision, and in posterior sub capsular cataract formation. Prolonged use may also suppress the host immune response and thus increase the hazard of secondary ocular infections. |
|
Adverse Reactions |
Elevation of intraocular pressure (IOP) with possible development of glaucoma and infrequent optic nerve damage, posterior sub capsular cataract formation, and delayed would heal. Transient burning and stinging upon instillation and other minor symptoms of ocular irritation have been reported with the use of prednisolone acetate suspension. |
|
Storage |
Store in a cool & dry place. Protect from light. |
|
Presentation |
PREDNIN A is available in sterile plastic bottle of 5ml. |
|